Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06620861 · ClinicalTrials.gov registry record · NA

Investigation on a New Power Knee Firmware Update on Gait and Daily Life Activities for Transfemoral Amputees

A NA study, sponsored by Össur Iceland ehf.

Terminated
Registry status
NA
Development phase
6
Enrollment target

NCT06620861: Clinical Trial NA study, sponsored by Össur Iceland ehf.

NCT06620861 is a NA study that was terminated before completion, run by Össur Iceland ehf. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT06620861, a NA study, was terminated before completion, sponsored by Össur Iceland ehf.

TERMINATED
Registry status
NA
Development phase
6 participants
Enrollment target

Study Summary

The goal of this interventional study is to investigate a new firmware in development for Power Knee on gait and daily life activities in unilateral transfemoral amputees. The main question it aims to answer is: What are the effects of a new firmware on sit-to-stand, level walking and stair ascent ? Researchers will compare both a new and the current marketed firmware to see if there is any changes in performance. Participants will be asked to perform some activities of daily living and some functional tests.

Primary Outcome

Each participant rated whether the new investigational firmware was worse, similar, or better compared to the current marketed firmware when performing sit to stand activity

Interventions

  • DEVICE Power Knee Firmware Update
  • DEVICE Power Knee Current Marketed Firmware

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2024-12-02
Est. Completion 2024-12-06
Phase NA
Össur Iceland ehf

10 total trials

Why NCT06620861 stopped before completion

NCT06620861 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 2 interventions - of which Power Knee Firmware Update is the first listed.

NCT06620861 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06620861 about?

NCT06620861 is a clinical study titled "Investigation on a New Power Knee Firmware Update on Gait and Daily Life Activities for Transfemoral Amputees". The goal of this interventional study is to investigate a new firmware in development for Power Knee on gait and daily life activities in unilateral transfemoral amputees. The main question it aims to answer is: What are the effects of a new firmware on sit-to-stand, level walking and stair ascent ...

What is the current status of trial NCT06620861?

This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2024-12-02. Estimated completion is 2024-12-06.

What interventions are being tested in trial NCT06620861?

The interventions under investigation include: Power Knee Firmware Update (DEVICE), Power Knee Current Marketed Firmware (DEVICE).

Who is sponsoring clinical trial NCT06620861?

This trial is sponsored by Össur Iceland ehf, which has 10 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06620861's enrollment target sits among peer trials

6 1983rd of 2000 higher than 13 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06620861, the US trial registry maintained by the National Library of Medicine. NCT06620861 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.